Assessing the 'Fit' older patient for chemotherapy

ONCOLOGY (United States)

Volumn 28, Issue 7, 2014, Pages

  Hurria, Arti ^a   Siccion, Eduardo P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; CANCER CHEMOTHERAPY; COMORBIDITY; DAILY LIFE ACTIVITY; FUNCTIONAL STATUS; GERIATRIC ASSESSMENT; HUMAN; HYPERTENSION; NUTRITIONAL STATUS; RISK ASSESSMENT; SOCIAL SUPPORT;

EID: 84904439123     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Smith BD, Smith GL, Hurria A, et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009; 27: 2758-65.
2. Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1948. p. 191-205.
3. Zubrod C, Schneiderman M, Frei E. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis. 1960; 11: 7-33.
4. Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011; 29: 3457-65.
5. Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012; 118: 3377-86.
6. Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007; 25: 1824-31.
7. Hurria A, Cirrincione C, Muss H, et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol. 2011; 29: 1290-6.
8. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963; 185: 914-9.
9. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9: 179-86.
10. Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005; 104: 1998-2005.
11. Hurria A, Cirrincione CT, Muss HB, et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol. 2011; 29: 1290-6.
12. Hurria A, Wildes T, Blair SL, et al. Senior adult oncology, version 2. 2014: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014; 12: 82-126.
13. Crawford J, Armitage J, Balducci L, et al. Myeloid growth factors. J Natl Compr Canc Netw. 2013; 11: 1266-90.
14. Aapro MS, Bohlius J, Cameron DA, et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer. 2011; 47: 8-32.
15. Sessums LL, Zembrzuska H Jackson JL. Does this patient have medical decision-making capacity? JAMA. 2011; 306: 420-7.
16. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012; 60: 616-31.